The Centers for Medicare and Medicaid Services (CMS) released a final Medicare rule yesterday that did not include a proposal that would have set hard limits on opioid pain medication at the pharmacy unless an insurer authorized special permission for a larger dose.
https://nap.nationalacademies.org/resource/24952/012318ecigaretteConclusionsbyEvidence.pdfSeven public health and medical groups, and several individual pediatricians, filed suit today in federal court in Maryland challenging a U.S. Food and Drug Administration (FDA) decision that allows electronic cigarettes and cigars – including candy-flavored products that appeal to kids – to stay on the market for years without being reviewed by the agency.
The U.S. Senate passed the Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act. The bipartisan bill would advance pediatric cancer research and increase transparency and expertise for pediatric cancer research at the National Institutes of Health (NIH).
The U.S. House of Representatives today passed an FY 18 federal budget, which includes; a $3 billion increase for medical research at the National Institutes of Health (NIH)—the largest such funding increase in 15 years; and a $275 million increase for the National Cancer Institute (NCI).
The House of Representatives tonight passed legislation that would change the process for accessing experimental drugs without including necessary patient safeguards. The Right-to-Try legislation was opposed by the American Cancer Society Cancer Action Network (ACS CAN) along with more than 80 other organizations representing millions of patients.
Twenty organizations representing millions of patients and consumers across the country sent a letter to the Secretaries of Health and Human Services, Labor and Treasury urging the administration to address patient concerns before finalizing troubling rules that as currently drafted would undermine access to affordable, comprehensive health coverage.
Food and Drug Administration (FDA) Commissioner Scott Gottlieb today announced an Advanced Notice of Proposed Rulemaking (ANPRM) aimed at assessing the role of flavoring in tobacco initiation, use and cessation.
Food and Drug Administration (FDA) Commissioner Scott Gottlieb today announced an Advanced Notice of Proposed Rulemaking (ANPRM) aimed at reducing nicotine levels in cigarettes to levels that no longer cause or sustain addiction.
Two reports released today highlight potentially dangerous findings among U.S. middle and high school students when it comes to advertising and perceptions of electronic cigarette and other tobacco products.
The House of Representatives tonight rejected legislation that would have changed the process for accessing experimental drugs without including necessary patient safeguards. The Right-to-Try legislation was opposed by the American Cancer Society Cancer Action Network (ACS CAN) along with more than 85 other organizations representing millions of patients.